Elsevier

Journal of Infection

Volume 85, Issue 3, September 2022, Pages e62-e65
Journal of Infection

Letter to the Editor
Pediatric patients with immune-mediated diseases on immunosuppressants have low risk of severe COVID-19 and no increase in flare rate after SARS CoV-2 exposure

https://doi.org/10.1016/j.jinf.2022.06.012Get rights and content

Highlights

  • •

    Pediatric patients on immunosuppressive drugs had mild COVID-19.

  • •

    Risk of flare related to SARS CoV-2 exposure in rheumatic disease patients was similar to baseline.

  • •

    Seroprevalence survey identified high asymptomatic infection rate.

Data for reference

  • The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Cited by (0)

View Abstract
© 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved.